Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US6907321029
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG000CTV5F0
ACH
Accendra Health, Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Medical Distribution · THEMEFOLIO: $HLTH
NAME
Accendra Health, Inc
ISIN
US6907321029
TICKER
ACH
MIC
XNYS
REUTERS
OMI.N
BLOOMBERG
ACH US
Mi., 24.06.2026       Accendra Health
US6907321029

Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced the expiration and final results of the previously announced offers to exchange (the “Exchange Offers”) any and all of the Company’s outstanding 4.500% Senior Notes due 2029 (the “2029 Notes”) and 6.625% Senior Notes due 2030 (the “2030 Notes” and, together with the 2029 Notes, the...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Mi., 10.06.2026       Accendra Health
US6907321029

Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced the early results of the previously announced offers to exchange (the “Exchange Offers”) any and all of the Company’s outstanding 4.500% Senior Notes due 2029 (the “2029 Notes”) and 6.625% Senior Notes due 2030 (the “2030 Notes” and, together with the 2029 Notes, the “Existing Notes...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Fr., 22.05.2026       Accendra Health
US6907321029

Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced that it has commenced an offer to exchange (the “Exchange Offers”) any and all of the Company’s outstanding 4.500% Senior Notes due 2029 (the “2029 Notes”) and 6.625% Senior Notes due 2030 (the “2030 Notes” and, together with the 2029 Notes, the “Existing Notes”). Eligible Holders o...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Mo., 11.05.2026       Accendra Health
US6907321029

Accendra Health, Inc. (NYSE: ACH) today reported financial results for the first quarter ended March 31, 2026, and announced a more than $1.5 billion comprehensive balance sheet optimization transaction with commitments from existing creditors that will strengthen the balance sheet, significantly extend maturities and reduce total leverage. Unless...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Fr., 01.05.2026       Accendra Health
US6907321029

Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the first quarter of 2026 on Monday, May 11, 2026, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. EDT on the same day. Participants may access the call via the toll-free d...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Do., 19.02.2026       Accendra Health
US6907321029

Accendra Health, Inc. (NYSE: ACH) today reported financial results for the fourth quarter ended December 31, 2025. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. “We ended the fourth quarter with th...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Do., 05.02.2026       Accendra Health
US6907321029

Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the fourth quarter of 2025 on Thursday, February 19, 2026, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EST on the same day. Participants may access the call via the toll-f...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Mi., 31.12.2025       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE: OMI) (the “Company”) announced the completion of the sale of its Products & Healthcare Services (P&HS) segment and the Owens & Minor brand to Platinum Equity and is renaming the publicly traded parent company Accendra Health, Inc. “Today’s announcement marks an inflection point in the strategic transfor...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Do., 18.12.2025       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE: OMI) (“the Company”) today announced that it will change its name to Accendra Health, Inc. with an anticipated effective date of December 31, 2025. The name change affects only the name of the parent corporation and is intended to better reflect the Company’s strategic direction and future organizational focus as a l...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Di., 02.12.2025       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE: OMI) announced today that members of its management team are scheduled to participate in two upcoming investor conferences. Citi 2025 Global Healthcare Conference On Tuesday, December 2, 2025, Ed Pesicka, the Company’s President and Chief Executive Officer, and Will Parrish, the Company’s Vice President of Strategy...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Do., 30.10.2025       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2025. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. “Our recent announcement on the sa...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Do., 16.10.2025       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the third quarter of 2025 on Thursday, October 30, 2025, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EDT on the same day. Participants may access the call via the toll-free dial-in numb...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Di., 07.10.2025       Accendra Health
US6907321029

Standalone P&HS anticipated to benefit from Platinum's carve-out experience, sector expertise and commitment to growth Owens & Minor to retain a 5% equity stake in the business LOS ANGELES, Oct. 7, 2025...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Di., 07.10.2025       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE: OMI) today announced that it has entered into a definitive agreement for the sale of the Company’s Products & Healthcare Services (P&HS) segment to Platinum Equity. Over the last several years, Owens & Minor has been strategically moving towards expanding its leadership position in the very attractive hom...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Mo., 15.09.2025       Accendra Health
US6907321029

Apria Healthcare, LLC and Byram Healthcare Centers, Inc., national leaders in home-based care and part of the Owens & Minor (NYSE: OMI) family, today announced a new national provider agreement with Optum Health – a patient-centered care organization that helps deliver better experiences for patients and providers, improve health outcomes and...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Do., 05.06.2025       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE: OMI) today announced it has mutually agreed with Rotech Healthcare Holdings Inc. to terminate the previously announced acquisition. Under the terms of the merger agreement, Owens & Minor has paid $80 million to Rotech Healthcare. Owens & Minor will also redeem the $1 billion of notes issued in April 2025, whi...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Do., 08.05.2025       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first quarter ended March 31, 2025. “Across the business we continued to see strong execution and progress towards our near and long-term strategies. Patient Direct delivered mid-single digit top-line growth with strong performance in nearly all therapy categories led by...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Do., 01.05.2025       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the first quarter of 2025 on Thursday, May 8, 2025, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:00 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Mi., 09.04.2025       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE: OMI) today announced important milestones in advancing the medical distribution capabilities of its Products & Healthcare Services (P&HS) business segment, which provides essential products and services to thousands of healthcare customers. These milestones are the result of recent company investments in new...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Mi., 02.04.2025       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE:OMI) (the “Company”) announced today the upsize and pricing of its private offering (the “Offering”) of $1 billion aggregate principal amount of its 10.000% senior secured notes due 2030 (the “Notes”). The Offering is expected to close on April 4, 2025, subject to customary closing conditions. The Notes will bear inte...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mi., 26.03.2025       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE:OMI) (the “Company”) announced today that it has launched a private offering (the “Offering”) of $600 million aggregate principal amount of senior secured notes due 2030 (the “Notes”), subject to customary and market conditions. Unless the previously announced acquisition (the “Acquisition”) of Rotech Healthcare Hold...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Fr., 28.02.2025       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2024. “We are pleased with the progress that we have made against the strategy as outlined at our Investor Day in December 2023. As a reminder, we committed to optimizing our Products & Healthcare Services business, leverag...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Di., 25.02.2025       Accendra Health
US6907321029

NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc ("Owens & Minor" or the "Company") (NYSE:OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Mi., 19.02.2025       Accendra Health
US6907321029

NEW YORK, Feb. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc ("Owens & Minor" or the "Company") (NYSE:OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Di., 11.02.2025       Accendra Health
US6907321029

NEW YORK, Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc ("Owens & Minor" or the "Company") (NYSE:OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Di., 11.02.2025       Accendra Health
US6907321029

Byram Healthcare, a leader in home-based care and part of the Owens & Minor (NYSE: OMI) family, recently launched ByramConnectTM, a personalized digital health program powered by the Welldoc App®. Using the Welldoc App’s advanced artificial intelligence capabilities, the program analyzes member data across six dimensions of health to help opti...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Mo., 03.02.2025       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE: OMI) (the “Company”) today announced selected preliminary financial results for the fourth quarter and year ended December 31, 2024 in advance of its upcoming earnings announcement and conference call. The release of the preliminary results relates to the Company’s commencement of financing activity related to its pr...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Mo., 02.12.2024       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE: OMI), announced today that members of its management team are scheduled to participate in two upcoming investor conferences. Citi 2024 Global Healthcare Conference On Wednesday, December 4, 2024, Owens & Minor is scheduled to participate in a fireside chat at 8:45 a.m. ET and host individual investor meetings a...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Mo., 04.11.2024       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2024. Key Highlights: Consolidated revenue of $2.7 billion in the third quarter, representing year-over-year growth of 5% GAAP Net loss of $(13) million or $(0.17) per share, and adjusted earnings per share of $0.42 in the third quar...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Mo., 21.10.2024       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the third quarter of 2024 on Monday, November 4, 2024, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day. Participants may access the call via the toll-free dial-in numbe...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Mo., 23.09.2024       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE: OMI), announced today that Mr. Jonathan Leon has been named Executive Vice President, Chief Financial Officer, effective immediately. Leon will maintain his corporate treasurer responsibilities while a search for his successor is underway. Mr. Leon has been with the Company since 2017, most recently serving as Interi...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Di., 10.09.2024       Accendra Health
US6907321029

Owens & Minor, Inc. today announced a new partnership with Google Cloud that combines Owens & Minor’s deep expertise in optimizing the healthcare supply chain with Google Cloud’s Vertex AI platform to help drive meaningful enhancements for QSight®, an industry-leading cloud-based clinical inventory management system from Owens & Minor....
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Mo., 09.09.2024       Accendra Health
US6907321029

Owens & Minor, Inc. (NYSE: OMI), announced today that Ed Pesicka, the Company’s President and Chief Executive Officer and Jon Leon, Corporate Treasurer and interim Chief Financial Officer, will participate in a fireside chat at 1:25 p.m. Eastern Daylight Time on Tuesday, September 10, 2024 at Baird’s Global Healthcare Conference in New York Ci...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Mo., 05.08.2024       Accendra Health
US6907321029

New York, New York--(Newsfile Corp. - August 5, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc. ("OMI" or the "Company") (NYSE: OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether OMI and certain of its of...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
So., 28.07.2024       Accendra Health
US6907321029

New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc. ("OMI" or the "Company") (NYSE: OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether OMI and certain of its off...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Do., 25.07.2024       Accendra Health
US6907321029

NEW YORK, July 24, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc. ("OMI" or the "Company") (NYSE: OMI).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Fr., 19.07.2024       Accendra Health
US6907321029

NEW YORK,, July 18, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc. ("OMI" or the "Company") (NYSE: OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Di., 16.07.2024       Accendra Health
US6907321029

New York, New York--(Newsfile Corp. - July 16, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc. ("OMI" or the "Company") (NYSE: OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether OMI and certain of its of...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Mi., 10.07.2024       Accendra Health
US6907321029

NEW YORK, July 10, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc. ("OMI" or the "Company") (NYSE: OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Mo., 08.07.2024       Accendra Health
US6907321029

New York, New York--(Newsfile Corp. - July 8, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc. ("OMI" or the "Company") (NYSE: OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether OMI and certain of its offi...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Di., 02.07.2024       Accendra Health
US6907321029

NEW YORK, July 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Owens & Minor, Inc. ("OMI" or the "Company") (NYSE: OMI).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink
Mo., 01.07.2024       Accendra Health
US6907321029

Boston, Massachusetts--(Newsfile Corp. - July 1, 2024) - Block & Leviton is investigating Owens & Minor, Inc. (NYSE: OMI) for potential securities law violations. Investors who have lost money in their Owens & Minor investment should contact the firm to learn more about how they might recover those losses. For more details, visit https:...
Zur Nachricht
Accendra Health
Charts & Research Termsheets Terminal
Permalink